Myriad Genetics Q4 2016 Earnings Call

Myriad Genetics reported FY2016 revenue of $753.8M with 4% year-over-year growth and adjusted EPS of $1.63. The company provided FY2017 guidance of $1.00–$1.10 non-GAAP diluted EPS, excluding acquisition-related charges and intangible asset amortization. The presentation includes forward-looking statements and reconciliation of GAAP to non-GAAP financial measures.